Molecular advances in early breast cancer.  Breast cancers are as diverse as the women who have them.  Now experts are using gene-based information to tailor treatment.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D003131:Combined Modality Therapy; D066246:ErbB Receptors; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases; D014481:United States; D016387:Women's Health
D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases; C512478:EGFR protein, human; C508053:ERBB2 protein, human